Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $81.82 +0.96%
EPS Growth %: +4.8%
Financial Fact:
Salaries: 4.11M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +4.8%
Financial Fact:
Salaries: 4.11M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $28.91 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Vail Resorts taps bankers for potential activist defense, Semafor reports
- SpaceX receives Baa1 rating from Moody's with stable outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
